Page 14 - Oncocyte News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oncocyte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oncocyte Today - Breaking & Trending Today
StockNews.com began coverage on shares of OncoCyte (NASDAQ:OCX – Get Rating) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. Separately, Needham & Company LLC dropped their target price on OncoCyte from $1.40 to $0.45 and set a buy rating on the stock in a report on Tuesday, […] ....
Equities researchers at StockNews.com started coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a research report issued on Tuesday. The firm set a “sell” rating on the stock. OncoCyte Price Performance Shares of OCX opened at $0.22 on Tuesday. OncoCyte has a 1 year low of $0.20 and a 1 year high of […] ....
StockNews.com assumed coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a report released on Sunday morning. The firm issued a sell rating on the stock. OncoCyte Trading Up 2.5 % Shares of NYSE OCX opened at $0.27 on Friday. OncoCyte has a 1-year low of $0.20 and a 1-year high of $1.35. The […] ....
OncoCyte (NASDAQ:OCX – Get Rating) will be posting its quarterly earnings results before the market opens on Thursday, May 11th. Analysts expect OncoCyte to post earnings of ($0.12) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link. OncoCyte Stock Performance Shares of OCX […] ....
StockNews.com began coverage on shares of OncoCyte (NYSE:OCX – Get Rating) in a report published on Sunday morning. The firm issued a sell rating on the stock. OncoCyte Price Performance Shares of NYSE OCX opened at $0.27 on Friday. OncoCyte has a 52-week low of $0.20 and a 52-week high of $1.35. The firm has […] ....